Editorial
doi: 10.1200/JCO.2005.02.913.
Epub 2005 Jun 27.
Enrichment designs: efficiency in development of cancer treatments
- PMID: 15983397
- DOI: 10.1200/JCO.2005.02.913
Item in Clipboard
Editorial
Enrichment designs: efficiency in development of cancer treatments
J Clin Oncol.
.
No abstract available
Comment on
-
Evaluation of randomized discontinuation design.J Clin Oncol. 2005 Aug 1;23(22):5094-8. doi: 10.1200/JCO.2005.02.520. Epub 2005 Jun 27. J Clin Oncol. 2005. PMID: 15983399
Similar articles
-
Improving the evaluation of new cancer treatments: challenges and opportunities.Nat Rev Cancer. 2003 Apr;3(4):303-9. doi: 10.1038/nrc1047. Nat Rev Cancer. 2003. PMID: 12671669 Review.
-
Multi-arm clinical trials of new agents: some design considerations.Clin Cancer Res. 2008 Jul 15;14(14):4368-71. doi: 10.1158/1078-0432.CCR-08-0325. Clin Cancer Res. 2008. PMID: 18628449 Review.
-
Clinical trials of parenteral antineoplastic agents.J Intraven Nurs. 1998 Nov-Dec;21(6):339-43. J Intraven Nurs. 1998. PMID: 10392099 Review.
-
Newer phase II trial designs gaining ground.J Natl Cancer Inst. 2007 Oct 3;99(19):1428-9. doi: 10.1093/jnci/djm182. Epub 2007 Sep 25. J Natl Cancer Inst. 2007. PMID: 17895467 No abstract available.
-
SRC as a potential therapeutic target in solid tumor oncology.Clin Adv Hematol Oncol. 2004 Jul;2(7):435-7. Clin Adv Hematol Oncol. 2004. PMID: 16163218 No abstract available.
Cited by
-
Advancing clinical trial design in pulmonary hypertension.Pulm Circ. 2013 Jan;3(1):217-25. doi: 10.4103/2045-8932.109933. Pulm Circ. 2013. PMID: 23662200 Free PMC article.
-
Cancer biomarkers: selecting the right drug for the right patient.Nat Rev Drug Discov. 2012 Feb 10;11(3):201-14. doi: 10.1038/nrd3651. Nat Rev Drug Discov. 2012. PMID: 22322254 Review.
-
PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome - 5 year follow-up of a prospective observational study.Clin Transl Radiat Oncol. 2020 May 30;24:23-28. doi: 10.1016/j.ctro.2020.05.008. eCollection 2020 Sep. Clin Transl Radiat Oncol. 2020. PMID: 32613088 Free PMC article.
-
Pharmacogenomics in early-phase oncology clinical trials: is there a sweet spot in phase II?Clin Cancer Res. 2012 May 15;18(10):2809-16. doi: 10.1158/1078-0432.CCR-11-2445. Epub 2012 Mar 16. Clin Cancer Res. 2012. PMID: 22427349 Free PMC article. Review.
-
Dose-escalation strategies which use subgroup information.Pharm Stat. 2018 Sep;17(5):414-436. doi: 10.1002/pst.1860. Epub 2018 Jun 13. Pharm Stat. 2018. PMID: 29900666 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
